# Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)

> **NCT00231439** · PHASE2,PHASE3 · COMPLETED · sponsor: **Haukeland University Hospital** · enrollment: 40 (—)

## Conditions studied

- Post-Polio Syndrome

## Interventions

- **DRUG:** IvIg

## Key facts

- **NCT ID:** NCT00231439
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2004-07
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231439, "Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT00231439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*